Ϫ secretion via phosphodiesterase modulation in the mouse jejunum.
PDE3; cystic fibrosis transmembrane conductance regulator; Ca 2ϩ -activated Cl Ϫ channels; milrinone GENISTEIN IS AN ISOFLAVONE phytoestrogen that occurs naturally in a number of soy-based products such as soy flour, soy milk, soybeans, and tofu (6) . In recent years, genistein has been linked to a range of potential health benefits, including the reduction of clinical symptoms of obesity, attenuation of bone loss in women, and decrease in the risk of prostate and breast cancer and cardiovascular disease (3, 6, 22, 38, 42, 46) . Additionally, genistein has been proposed as a promising pharmacotherapeutic for cystic fibrosis, through its modulation of ion transport proteins involved in the Cl Ϫ secretory response of specific epithelial tissues (1, 2, 57, 59) . Understanding the basic mechanism of action of genistein on cellular functions is necessary for further pharmacological development of genistein as a pharmacotherapeutic agent for diseases in epithelial tissues, for example.
In native epithelia and cultured epithelial cell lines, the Cl Ϫ secretory response occurs through the concerted effort of four membrane transport proteins. In the mouse jejunum, the crypt is the site of Cl Ϫ secretion (13, 70) . The predominant apical Cl Ϫ channel of the jejunal crypt enterocyte is the cystic fibrosis transmembrane conductance regulator (CFTR, a cAMP-dependent Cl Ϫ channel); however, two Ca 2ϩ -activated Cl Ϫ channels (CLCA) have been recently identified in the mouse jejunum, CLCA3 and CLCA6. CLCA3 is confined to the small population of goblet cells of the crypts and villi (45) , while CLCA6 is only located in the villi of the small intestine (8, 23) . The basolateral membrane of the jejunal crypt cells possesses the Na
Ϫ cotransporter, K ϩ channels, and the Na ϩ -K ϩ -ATPase. For a sustained Cl Ϫ secretory response to occur, all of the basolateral transport proteins must be active to transport Cl Ϫ into the cell across the basolateral membrane and maintain intracellular Cl Ϫ above its electrochemical equilibrium (56) , after which activation of CFTR allows Cl Ϫ to pass across the apical membrane, resulting in Cl Ϫ secretion (67) . CFTR is modulated/activated by phosphorylation via a cAMP-dependent mechanism (26, 62) . Cellular levels of cAMP are maintained through a fine balance of cAMP synthesis by adenylyl cyclase and cAMP degradation by the action of phosphodiesterases (PDEs). Differential modulation of adenylyl cyclase or PDEs would alter cellular cAMP levels and, therefore, the activation of CFTR via phosphorylation by protein kinase A (PKA). For example, inhibition of PDEs would maintain elevated levels of cAMP resulting in increased Cl Ϫ secretion in tissues such as the jejunum of the small intestine.
It is now generally accepted that cAMP, adenylyl cyclase, and PDEs are compartmentalized in various domains within the cytosol and cellular membrane (18, 48, 53, 58) . Indeed, cAMP signaling pathways appear to be orchestrated via Akinase-anchoring proteins that coordinate the spatial and temporal response of the signaling pathways (5, 17, 60, 63) . As a result, a prevalent cellular PDE might not participate in the regulation of a specific membrane protein. For example, Zaccolo and coworkers reported that even though both PDE3 and PDE4 were important PDEs in modulating cAMP levels of rat cardiac myocytes, PDE4 was responsible for modulating cAMPdependent ␤-adrenergic receptor function, suggesting compartmentalization of these PDEs (49) . Therefore, a PDE that is important for overall cAMP hydrolytic activity of a particular cell may not be the key PDE in terms of transport protein function.
Genistein modulates the functions of many ion transport proteins, including the CFTR (4, 19, 27, 44) , K ϩ channels (20, 33) , and the Na
Ϫ cotransporter (51, 65) , all of which participate in Cl Ϫ secretion. Ultimately, the resulting Cl Ϫ secretion stimulated by genistein is via cAMP-sensitive CFTR Cl Ϫ channels. However, the mode of action(s) of genistein on ion transport proteins is highly controversial, and many mo-lecular mechanisms have been proposed, including a direct activation of CFTR (25, 68) , modulation of tyrosine kinases (37, 61) , protein phosphatases (37, 55) , or protein kinases (61) .
The crypt region of the jejunum is the primary site for epithelial fluid and electrolyte secretion by the intestine, including Cl Ϫ secretion (13) . Recently, we provided the first report on the effects of genistein on the mouse jejunum (4) . In that study, recording short-circuit currents (I sc ) and using a pharmacological approach, we demonstrated that genistein stimulated a sustained increase in Cl Ϫ secretion and that the action of genistein involved, at a minimum, both CFTR and the Na ϩ -K ϩ -2Cl Ϫ cotransporter (4). We proposed that genistein acted by a phosphorylation-dependent mechanism, and to test that, we examined the effect of forskolin, an activator of adenylyl cyclase, on I sc in the presence of genistein. The I sc forskolin-stimulated response was significantly reduced in the presence of genistein. Additionally, pretreating the jejunum with forskolin eliminated the action of genistein on the I sc . We concluded that genistein regulated Cl Ϫ secretion of the mouse jejunum by a phosphorylation-dependent pathway (4) .
O'Grady et al. (52) demonstrated that modulation of PDEs altered the cAMP-dependent Cl Ϫ secretion in human colonic epithelial cells (T84). They reported that PDE4 accounted for Ͼ70% of the total cAMP hydrolysis in both cellular and membrane fractions from these cells. However, PDE1 and PDE3 also played crucial roles in modulating Cl Ϫ secretion of T84 cells (52) . Additionally, Steagall and Drumm (64) demonstrated the presence of PDE1, PDE3-PDE5 in the epithelium of the mouse intestine. They (64) also demonstrated that inhibition of these four PDEs stimulated small increases of I sc of the mouse jejunum, suggestive of a cAMP-phosphorylation-dependent increase in current by the jejunum. Recently, Ko et al. (40) and Nichols and Morimoto (50) have demonstrated that genistein is an effective inhibitor of PDE1-4.
To date, a systematic examination of the role of genistein in the modulation of PDEs in the Cl Ϫ secretory response of the mouse jejunum has not been carried out. Therefore, the aims of the present study were first, to examine the effects of selective inhibitors of PDEs on the I sc of the mouse jejunum, and second, to determine the role of PDEs in the mechanism of action of genistein on the Cl Ϫ secretory response of the mouse jejunum.
MATERIALS AND METHODS
Animals and tissue preparation. All experiments were carried out on the jejunum of male Swiss-Webster mice (20 to 35 g) and were approved by the University of Otago Animal Ethics Committee. The animals had access to tap water and food ad libitum. Mice were killed by cervical dislocation. The isolated jejunum was placed in and flushed with a NaCl Ringer solution [in mM: 140 NaCl, 5 KCl, 2 CaCl 2, 1 MgCl2, 10 HEPES/tris(hydroxymethyl)methylamine (Tris), and 4 pyruvate/glutamine, with pH adjusted to 7.4]. The HEPESbuffered Ringer was used for examining HCO 3 Ϫ -independent Cl Ϫ secretory responses. Electrophysiological measurements-Ussing chamber experiments. Ussing chamber I sc experiments were conducted as previously described (4, 11, 31) . Once the tissues were pinned, they were glued (Loctite 454, Herts Garden City, UK) to plastic annuli (0.7 cm 2 ) and mounted in modified Ussing chambers. In all experiments, tissues were bathed on both mucosal and serosal sides with 10 ml of the NaCl Ringer solution. Solutions were aerated (100% O 2) and maintained at 37°C by water-jacketed solution reservoirs.
Tissues were voltage clamped to 0 mV (Biodesign; South Campus Electronics, University of Otago). I sc was continuously recorded with a MacLab data acquisition system and analyzed with MacLab Chart (version 3.6.3, AD Instruments, Castle Hill, Australia). Initially, tissues were rinsed three times with NaCl Ringer. Then, all tissues were pretreated (1 h) with indomethacin (1 M, mucosal and serosal) to reduce prostaglandin production (24) and tetrodotoxin (TTX, 1 M, serosal) to decrease enteric nerve activity (34) to reduce the rate of transepithelial transport to basal conditions. The basal I sc was 130 Ϯ 3 A/cm 2 [n ϭ 339; not different from our previous studies (4, 30, 31) ]. The change in Isc (⌬Isc) induced by a treatment was expressed as the difference from the former baseline to the steadystate value. Effects on I sc were compared against changes in Isc of time-matched control tissues. Data from concentration-dependent response experiments were fitted with the Hill equation (for details of the Hill equation, see Ref. 69) . The presence of the circular and longitudinal muscle layers outside the epithelium did not impede access of chemicals to the epithelium, as illustrated by very rapid responses of I sc with the addition of theophylline, milrinone, or bumetanide (e.g., see Figs. 1-4, 6 ).
We were concerned that the basal I sc of a tissue might influence the response of genistein on I sc. However, the amount of genisteininduced Isc was not correlated with the magnitude of the basal Isc present (P ϭ 0.7, n ϭ 40, data not shown).
Chemicals. Bumetanide, erythro-9-(2-hydroxyl-3-nonyl)-adenine (EHNA), forskolin, genistein, HEPES, indomethacin, milrinone, 8-methoxymethyl-3-isobutyl-1-methylxanthine (MM-IBMX), rolipram, and theophylline were purchased from Sigma Chemical (St. Louis, MO). H89 was obtained from Calbiochem (La Jolla, CA). TTX was purchased from Alomone Labs (Jerusalem, Israel), and Tris-(hydroxymethyl)aminoethane (Tris) was obtained from BDH Chemicals (Poole, UK). EHNA, genistein, milrinone, MM-IBMX, and rolipram were dissolved in dimethyl sulfoxide (DMSO), bumetanide was dissolved in ethanol, and indomethacin was dissolved in methanol. H89, HEPES, Tris, and TTX were dissolved in distilled water. Theophylline was added as anhydrous crystals. Drugs were added as a small volume of a stock solution unless otherwise stated.
Statistical analysis. Statistical significance was assessed using Student's t-test (paired and unpaired). A P value of Յ0.05 was considered statistically significant. MacCurveFit (Kevin Raner Software, Mt. Waverley, Victoria, Australia) was used for curve fitting and determining the EC 50, apparent Vmax value, and a Hill coefficient for the concentration-dependent response experiments. Data are presented as means Ϯ SE. The number (n) of tissues and number of (N) animals for a given protocol and a series of experiments, respectively, are provided in the text. Sometimes more than one tissue from an animal was used for a particular protocol within a given series of experiments.
RESULTS

Genistein and theophylline activation of Cl
Ϫ secretion by the mouse jejunum. Previously, we demonstrated that genistein stimulated a sustained concentration-dependent Cl Ϫ secretory response of mouse jejunum (4) . Initially, we confirmed our previous findings (4) . As can be seen in Fig. 1 , genistein (75 M, mucosal and serosal) activated an increase in I sc of 36 Ϯ 9 A/cm 2 ( Fig. 1C , n ϭ 7, N ϭ 7). The genistein-stimulated I sc was significantly higher than the change in I sc of the DMSO control tissues (Ϫ8 Ϯ 4 A/cm 2 , n ϭ 4) that received vehicle only (Fig. 1, B and C) . We used bumetanide, an inhibitor of Na
Ϫ cotransporter, to confirm that the genisteinactivated I sc was, indeed, due to Cl Ϫ secretion. Bumetanide (20 M, serosal) significantly reduced (28 Ϯ 7 A/cm of the genistein-stimulated I sc may be due to HCO 3 Ϫ secretion (28); in this case, the HCO 3 Ϫ must have been generated from a cellular source since these experiments were conducted in HEPES-buffered Ringer.
It has been reported that genistein can regulate Cl Ϫ secretion by altering the phosphorylation state of CFTR through inhibition of protein kinases (37, 61) or protein phosphatases (36, 37, 55) . Additionally, modulation of phosphodiesterases (PDEs) would result in elevated levels of cAMP leading to activation of CFTR. At present, the modulation of Cl Ϫ secretion by genistein's actions on PDEs of native tissues is not well understood. Initially, we used theophylline [a nonselective inhibitor of PDEs (10)] to establish an action of genistein on PDEs that resulted in the Cl Ϫ secretory response by the mouse jejunum.
We predicted that theophylline by itself would increase the I sc of the mouse jejunum based on the fact that Cl Ϫ secretion, via CFTR, is through a cAMP-dependent pathway. To test this hypothesis, first tissues were subjected to theophylline (10 mM, serosal) or received no drug followed by the addition of bumetanide (10 M, serosal) to all tissues. Theophylline stimulated a sustained increase in I sc (64 Ϯ 6 A/cm 2 , n ϭ 16; N ϭ 8) (Fig. 2 , A and C) that was greater (P Յ 0.001) than time-matched control tissues (Ϫ2 Ϯ 1 A/cm 2 ; n ϭ 15) (Fig.  2C) . Addition of bumetanide reduced the theophylline-activated I sc by 57% (40 Ϯ 6 A/cm 2 , n ϭ 8) (Fig. 2 , A and C). Additionally, the reduction of I sc by bumetanide was greater (P Յ 0.001) in theophylline-stimulated tissues compared with time-matched control tissues (Fig. 2, A and C ). These data demonstrate that a large portion of I sc stimulated by theophylline was due to Cl Ϫ secretion.
Do genistein and theophylline share a common pathway in activating Cl
Ϫ secretion? We predicted that if genistein's action on Cl Ϫ secretion was via a PDE-dependent pathway, then the pretreatment of tissues with theophylline would reduce the effect of genistein on the I sc . We used 13 animals to test this hypothesis. For each experiment, two tissues were pretreated with theophylline (10 mM, serosal), followed by the addition of either genistein (75 M, mucosal and serosal) or DMSO (not shown). A third tissue received genistein only, and the last tissue received DMSO only. Bumetanide (10 M, serosal) was added to all tissues at the end of the experiment. Genistein stimulated a sustained increase of I sc (24 Ϯ 3 A/cm 2 , n ϭ 12) in the absence of theophylline as shown in Fig. 3 , A and D. Pretreatment of tissues with theophylline increased I sc by 62 Ϯ 9 A/cm 2 (n ϭ 7) (Fig. 3B ). Now, in the presence of theophylline, genistein did not increase I sc . However, there was a small reduction of I sc (Ϫ9 Ϯ 4 A/cm 2 , n ϭ 12), which was not significantly different from the effects of DMSO on the control tissues or of DMSO added to the theophylline-stimulated tissues (Fig. 3D ). On the basis of those results, we predicted that pretreating tissues with genistein would reduce the effect of theophylline on I sc . Tissues were pretreated with either genistein (75 M, mucosal and serosal) or DMSO, and then both tissues received theophylline (10 mM, serosal) followed by bumetanide (20 M, serosal). In the absence of genistein, theophylline stimulated a sustained increase in I sc of 67 Ϯ 14 A/cm 2 (n ϭ 7, N ϭ 7) (Fig. 4, A and C) . However, in the presence of genistein, the theophylline-stimulated I sc was reduced (P Յ 0.05) by 51% (34 Ϯ 7 A/cm 2 , n ϭ 6; N ϭ 6) (Fig. 4, B and C) . These results suggest that genistein and theophylline share a common pathway in activating Cl Ϫ secretion in the mouse jejunum and that this is potentially via a PDE-sensitive pathway.
Genistein-stimulated Cl Ϫ secretory response is independent of PDE1. Genistein has been shown to be an effective inhibitor of PDE1-4 (40, 50) . To examine the participation of specific PDEs in the genistein-stimulated Cl Ϫ secretory response in the mouse jejunum, we examined the effects of genistein in the presence of specific inhibitors of various isoforms of PDEs.
One possible action of genistein is to inhibit PDE1, thus resulting in the stimulation of Cl Ϫ secretion. To test this hypothesis, we used MM-IBMX (100 M, mucosal and serosal), a selective inhibitor of PDE1 (21) , which has been used to inhibit PDE1 activity of mouse jejunum and T84 cell monolayers (52, 64) . Six animals were used in the series of experiments. Tissues received genistein (75 M, mucosal and serosal) in the absence (DMSO added to the control tissue) or presence of MM-IBMX, followed by bumetanide (10 M, serosal). MM-IBMX (n ϭ 6) alone did not alter the basal I sc of the tissues compared with time-matched DMSO control tissues (data not shown). The stimulation of I sc by genistein was not significantly different in the presence (⌬I sc ϭ 19 Ϯ 3 A/cm 2 , n ϭ 6; N ϭ 6) or absence (⌬I sc ϭ 16 Ϯ 3 A/cm 2 , n ϭ 6) of MM-IBMX. Bumetanide reduced (P Յ 0.05) the genisteinstimulated I sc under both experimental instances (8 Ϯ 3 A/ cm 2 and 12 Ϯ 1 A/cm 2 in the absence and presence of MM-IMBX, respectively; n ϭ 6 for both). Steagall and Drumm (64) reported that MM-IBMX (100 M) activated a "small" increase in I sc (ϳ15 A/cm 2 ) of the mouse jejunum. However, it should be noted that in Steagall and Drumm's study, tissues were bathed in HCO 3 Ϫ -containing Ringer rather than HEPES Ringer and were not pretreated with indomethacin or TTX.
These data suggest, under our experimental conditions, that MM-IBMX does not stimulate I sc . Additionally, these data suggest that the genistein-activated Cl Ϫ secretory response was not altered in the presence of MM-IBMX, strongly suggesting that the mechanism of genistein-induced Cl Ϫ secretion is independent of PDE1.
Genistein-activated a PDE2-independent Cl Ϫ secretory response. Blockers of PDE2 have been used to demonstrate cAMP-dependent transport in tissues. For example, EHNA, a selective blocker of PDE2 (21), prevented nitric oxide from inhibiting cAMP-activated NaCl transport of the rat thick ascending limb (54) . Therefore, we wanted to test the hypothesis that genistein increased I sc via inhibition of PDE2. To test our hypothesis, we examined the effect of genistein (75 M, mucosal and serosal) on the I sc of two tissues bathed in NaCl Ringer in the absence or presence of EHNA while a third tissue received DMSO (vehicle) alone. Initially, we used 100 M EHNA (mucosal and serosal), which had no effect on basal I sc (data not shown). However, the combination of 100 M EHNA and genistein (or vice versa) led to deleterious effects on the transport properties of the mouse jejunum (n ϭ 8, data not shown). Subsequently, we conducted all experiments with 40 M EHNA. Two tissues received EHNA while another two tissues received DMSO, after which all tissues were subjected to genistein (75 M, mucosal and serosal) followed by bumetanide (10 M, serosal). Addition of 40 M EHNA did not alter the basal I sc (n ϭ 6) when compared with the effect of DMSO (vehicle) on I sc of control tissues (n ϭ 6), suggesting no effect of PDE2 on basal I sc (data not shown). Additionally, the genistein-stimulated I sc was the same in the absence (13 Ϯ 2 A/cm 2 ) or presence (16 Ϯ 1 A/cm 2 ) of EHNA. The genistein-stimulated I sc was significantly (P Յ 0.05) blocked by bumetanide. Similarly, with the reverse experiment, EHNA did not reduce the genistein-stimulated I sc (n ϭ 4, data not shown). These data suggest that under these experimental conditions, genistein stimulates Cl Ϫ secretion by a PDE2-independent mechanism.
Genistein-activated Cl Ϫ secretory response involves inhibition of PDE3. On the basis of the presence of PDE3 in the mouse jejunum (64) and the report by O'Grady and colleagues (52) that Cl Ϫ secretion is PDE3 dependent in T84 cells, we tested the hypothesis that genistein stimulates Cl Ϫ secretion in the mouse jejunum by inhibition of PDE3. Initially, we wanted to advance the work of Steagall and Drumm (64) by determining the concentration-dependent effect of milrinone (0.1-300 M, mucosal and serosal), a known inhibitor of PDE3 (47), on I sc of the mouse jejunum. The increase in I sc stimulated by milrinone was dose dependent with an EC 50 of 46 Ϯ 9 M, an apparent V max of 81 Ϯ 7 A/cm 2 , and a Hill coefficient of 1.1 Ϯ 0.1 (Fig. 5 , n ϭ 6 -13 per concentration; N ϭ 6). Again, DMSO had no effect on basal I sc . Addition of bumetanide (10 M, serosal) significantly (P Յ 0.05) decreased the milrinoneinduced I sc (60 Ϯ 4%, n ϭ 5), which was consistent with a Cl Ϫ secretory response (data not shown).
If genistein increases I sc by inhibiting PDE3, then we predicted that genistein might still increase I sc in the presence of a submaximal concentration of milrinone (100 M), unless milrinone is a more potent inhibitor of PDE3. To test this hypothesis, we examined the effect of genistein on I sc in the presence of 100 M milrinone (8 animals). One tissue was pretreated with milrinone (mucosal and serosal) followed by the addition of DMSO, the second and third tissues received either milrinone or DMSO followed by genistein (75 M, mucosal and serosal), while the fourth tissue was a timematched control receiving only DMSO. All tissues received bumetanide (10 M, serosal) at the end of the experiment. Milrinone increased the I sc by 106 Ϯ 11 A/cm 2 (n ϭ 13) (Fig. 6 , A, C, and E). As seen in Fig. 6B , genistein stimulated an increase in I sc (13 Ϯ 7 A/cm 2 , n ϭ 8) in the absence of milrinone (Fig. 6F, n ϭ 8) . However, genistein failed to increase I sc in the presence of milrinone, and indeed, the milrinone-induced I sc was reduced by genistein (Fig. 6 , C and F, n ϭ 6). The reduction of I sc by genistein (Ϫ19 Ϯ 3 A/cm 2 , n ϭ 6) (Fig. 6F ) in the presence of milrinone was greater (P Յ 0.01) compared with either the effect of DMSO on the timematched control tissue (⌬I sc ϭ Ϫ5 Ϯ 4 A/cm 2 , n ϭ 3, Fig.  6D ) or on the milrinone control tissue (⌬I sc ϭ 6 Ϯ 4 A/cm 2 , n ϭ 3, Fig. 6A ). These data strongly suggest that milrinone and genistein share a common pathway by inhibiting PDE3 resulting in Cl Ϫ secretion in the mouse jejunum. On the basis of those results (Fig. 6) , we hypothesized that genistein would reduce the effect of milrinone on I sc but not eliminate milrinone's effect on I sc . Therefore, similar experiments were conducted as described above (7 animals). Two tissues were pretreated with genistein (75 M, mucosal and serosal) while the third tissue received DMSO, after which milrinone (100 M, mucosal and serosal) was added to one of the two genistein-treated tissues and DMSO was added to the other tissue. Bumetanide (10 M, serosal) was added to all tissues at the end of the experiment. Milrinone increased I sc by 100 Ϯ 10 A/cm 2 ( Fig. 7 , A and D; n ϭ 7). However, in the presence of genistein, the milrinone-stimulated I sc (55 Ϯ 8 A/cm 2 ) was reduced by 48 Ϯ 9% (P Յ 0.01) (Fig. 7 , B and D; n ϭ 7) compared with milrinone alone while DMSO had no effect (⌬I sc ϭ 1 Ϯ 1 A/cm 2 ) on the genistein-stimulated tissue (Fig. 7, C and D; n ϭ 5 ).
These data demonstrate, for the first time, that genistein stimulates Cl Ϫ secretion via a PDE3-dependent manner in native epithelium. Genistein-stimulated I sc response was reduced by the presence of a PDE4 inhibitor. Using PDE assays, O'Grady and colleagues (52) reported that PDE4 accounted for the major fraction of the total cAMP hydrolytic activity of T84 colonic epithelial cells. However, PDE4 was not involved in Cl Ϫ secretion as assessed by I sc experiments. Rolipram is a specific inhibitor of many isoforms of PDE4 (12, 16) and has been used to determine the role of PDE4 in a number of tissues (7) .
We used rolipram to test the hypothesis that genistein stimulated Cl Ϫ secretion of the mouse jejunum by inhibition of PDE4. Ten animals were used in the series of experiments. Two tissues were pretreated with either 40 M or 100 M rolipram (mucosal and serosal) while another two tissues received DMSO, after which all tissues received genistein (75 M, mucosal and serosal) followed by bumetanide (10 M, serosal). Genistein stimulated the I sc by 24 Ϯ 4 A/cm 2 ( Fig. 8, B, D , and E; n ϭ 10), while the genistein vehicle, DMSO, reduced the I sc by 10 Ϯ 5 A/cm 2 (n ϭ 14; trace not shown). Rolipram did not affect the basal I sc (Ϫ9 Ϯ 4 A/cm 2 , n ϭ 14, data not shown) when compared with time-matched control tissues (Ϫ9 Ϯ 3 A/cm 2 , n ϭ 11, data not shown), which suggests that PDE4 did not contribute to the basal I sc .
Similarly, 100 M rolipram did not affect the basal I sc (Ϫ13 Ϯ 4 A/cm 2 , n ϭ 12) when compared with time-matched control tissues (Ϫ8 Ϯ 3 A/cm 2 , n ϭ 12) (data not shown). In the presence of 40 M rolipram, genistein stimulated I sc by only 8 Ϯ 4 A/cm 2 ( Fig. 8 , A and E; n ϭ 10), and genistein activated the I sc by 10 Ϯ 7 A/cm 2 in the presence of 100 M rolipram (Fig. 8, C and E; n ϭ 9) . Hence, there was a reduction in the genistein-stimulated I sc in the presence of both 40 M (P Յ 0.01) and 100 M (P Յ 0.05) rolipram (Fig. 8E) . These data suggest that rolipram did not alter the basal I sc . However, the pretreatment of the tissues with rolipram reduced the genistein-stimulated I sc , thus suggesting a regulatory link between PDE4 and genistein's effect on I sc .
Is the milrinone-stimulated Cl Ϫ secretion PKA dependent? The level of intracellular cAMP is a fine balance between the activities of adenylyl cyclase and PDEs. Obviously, if a particular PDE is downregulated, then the level of cAMP can be increased, resulting in the activation of PKA. Subsequently, this increased PKA can phosphorylate CFTR, resulting in Cl Ϫ secretion (62) . Recently, for the mouse jejunum, we (30) have used H89, a PKA inhibitor (32) , to demonstrate that the forskolin-and 5,6-dichloro-1-ethyl-1,3-dihydro-2H-benzimi- 
dazol-2-one (DCEBIO)-stimulated Cl
Ϫ secretory responses were PKA dependent. Therefore, we have taken a similar approach to determine whether the milrinone-and genisteinstimulated Cl Ϫ secretory responses are PKA dependent. We hypothesized that milrinone inhibits PDE3 to activate I sc by a PKA-dependent pathway (Fig. 6E) , and then pretreatment of tissues with H89 should attenuate the stimulatory action of milrinone on I sc . To test this hypothesis, our experimental protocol consisted of pretreating one tissue with H89 (50 M, serosal) followed by milrinone (100 M, mucosal and serosal) while water (vehicle for H89) was added to the control tissue followed by milrinone. All tissues received bumetanide (10 M, serosal) at the end of the experiment. Similar to the water control tissues (Fig. 9A) , H89 did not affect the basal I sc (Fig.  9B ) compared with water, as we previously reported (30) . In the absence of H89, milrinone stimulated an increase in I sc of 60 Ϯ 6 A/cm 2 ( Fig. 9 , A and C, n ϭ 8, N ϭ 8). However, in the presence of H89, the increase in milrinone-activated I sc was reduced (P Յ 0.01, 33% block) to only 40 Ϯ 4 A/cm 2 (Fig. 9, B and C, n ϭ 8; N ϭ 8). Additionally, the bumetanidesensitive I sc was greater (P Յ 0.01) for the milrinone-stimulated I sc in the absence of H89 compared with in the presence of H89. These results clearly demonstrate that there is no basal PKA activity and that, furthermore, the milrinone-stimulated I sc is dependent on PKA. These results strongly suggest that the Cl Ϫ secretory response is attributed to the inhibition of PDE3 by milrinone.
Is the genistein-stimulated Cl Ϫ secretion PKA dependent? The milrinone and genistein data (Figs. 6 and 7) indicate that the action of these two modulators on Cl Ϫ secretion is by a shared cAMP-dependent pathway. Thus, we hypothesize that since genistein activates Cl Ϫ secretion via a PKA-dependent pathway, then genistein's action on I sc should be reduced in the presence of H89. To test this hypothesis, we examined the action of genistein in the absence and presence of H89. Five animals were used in this series of experiments. Two tissues were either pretreated with water or H89 (50 M, serosal) followed by the addition of genistein (75 M, mucosal and serosal). Bumetanide (10 M, serosal) was added to both tissues at the end of an experiment. As can be seen in Fig. 10 , genistein stimulated an increase in I sc of 19 Ϯ 6 A/cm 2 ( Fig.  10, A and C, n ϭ 5) . However, the genistein-stimulated I sc was significantly (P Յ 0.05) reduced to 7 Ϯ 3 A/cm 2 (63% reduction) in the presence of H89 (Fig. 10 , B and C, n ϭ 5). Furthermore, the bumetanide-sensitive, genistein-stimulated I sc was greater (89%) for the tissues that were exposed to genistein in the absence (P Յ 0.05, n ϭ 5) rather than the presence of H89. To our knowledge, this is the first evidence that genistein activates Cl Ϫ secretion of the mouse jejunum by inhibition of PDE3 and that genistein's action is via a PKA-dependent pathway.
DISCUSSION
Genistein-PDE3-dependent modulation of Cl
Ϫ secretion. The present study extends our previous work on the action of genistein on the Cl Ϫ secretory process of the mouse jejunum (4). The aims of our current study were to examine the effects of selective inhibitors of PDEs on the I sc of the mouse jejunum and to examine the action of genistein on PDEs in the modulation of Cl Ϫ secretion of the mouse jejunum. Initially, we used theophylline, a generic PDE inhibitor, to demonstrate that the basal I sc and genistein-stimulated I sc were PDE dependent (Figs. 2-4) , after which we used specific inhibitors of PDEs to establish which PDE(s) was involved in the genistein-stimulated Cl Ϫ secretory response. We demonstrated that MM-IMBX and EHNA did not alter the basal I sc of the jejunum or reduce the action of genistein on I sc , suggesting that PDE1 and PDE2 were not involved in the basal I sc or genistein-stimulated I sc . On the other hand, even though rolipram, an inhibitor of PDE4, failed to alter basal I sc , the genistein-activated I sc was reduced in the presence of rolipram (Fig. 8) . While this was an intriguing observation, this was, however, not pursued in the current study. Here, we describe, for the first time in the mouse jejunum, that milrinone stimulates a bumetanide-sensitive, concentration-dependent increase in I sc , indicative of Cl Ϫ secretion. More importantly, we report, for the first time, that genistein stimulates Cl Ϫ secretion by a PDE3-and PKA-dependent manner.
Several lines of evidence suggest that the activation of Cl Ϫ secretion by genistein is via a PDE3-and PKA-dependent mechanism. First, pretreatment of the jejunum with a submaximal concentration (100 M) of milrinone prevented a further increase in I sc by genistein (Fig. 6, C and F) . Interestingly, genistein reduced I sc in the presence of milrinone and is discussed below. Second, pretreatment of the jejunum with genistein reduced the milrinone-stimulated I sc by nearly 50% (Fig. 7, B and D) . These data suggest that genistein and milrinone share a common pathway (via PDE3) for increasing Cl Ϫ secretion of the mouse jejunum. Third, we have previously (4) reported that pretreating the jejunum with a maximal concentration of forskolin prevented genistein from stimulating I sc of the mouse jejunum, suggesting that genistein increases Cl Ϫ secretion by resulting in the phosphorylation of CFTR via a PKA-dependent pathway. Also in that study, we demonstrated that genistein decreased the forskolin-stimulated I sc . Lastly, in our present study, H89, an inhibitor of PKA, significantly reduced the genistein-stimulated I sc and the genisteinstimulated bumetanide-sensitive I sc (Fig. 10) . These data strongly suggest that genistein's activation on Cl Ϫ secretion in the mouse jejunum is via a PDE3-and PKA-dependent mechanism.
We strongly believe that CFTR is the apical Cl Ϫ channel involved in the genistein-activation Cl Ϫ secretion. However, two Ca 2ϩ -activated Cl Ϫ channels (CLCA) have been recently identified in the mouse jejunum, CLCA3 and CLCA6. CLCA3 is located in the goblet cells of the small intestine (villi and crypts) (45) , while CLCA6 is isolated only in the villi of the small intestine (8, 23 (39) suggested that the inconsistency between the effects of inhibitors of PDEs on cAMP and on transport function may reflect the compartmentalized action of PDEs, and that PDE3 was located where it could have the greatest influence on CFTR, for example. In their study, Kelley et al. (39) did not identify the compartment(s) (cytosolic or membrane) where PDE3 was located. However, PDE3 has been localized within the cellular membrane of other epithelia (52, 58) . For example, O'Grady and coworkers (52) demonstrated that PDE3 only inhibited 25% of the cAMP-phosphodiesterase activity of the membrane fraction. But PDE3 played a significant role in the Cl Ϫ secretory response of T84 cells. Also, Cobb et al. (15) reported that inhibition of PDE3 increased I sc of Calu-3 cells in the absence of changes in cAMP, again, suggesting compartmentalization of the function of PDE3. So, modulation of Cl Ϫ secretion by inhibition of PDE3 clearly occurs in epithelia.
From our results, one might contend that the genisteinstimulated I sc is dependent on an elevation of cAMP. This may be the case; however, the ability of genistein to alter cellular levels of cAMP has been debated over the years. In epithelia, many have demonstrated that elevated levels of cAMP are not required for a sustained genistein-stimulated Cl Ϫ secretory response (35-37, 44, 61) . However, some have reported that genistein increased cAMP levels (9) . The studies referenced here have been conducted in cultured cell lines where there is ease of isolation and quantity of isolated cells. Unfortunately, the anatomical structure of the jejunum is complex, with an elaborate arrangement of the crypts and villi (13) . The crypt region of the jejunum is the primary site for Cl Ϫ secretion (70) . Therefore, to determine the effects of genistein on the cAMP levels of the cellular and membrane fractions of the crypt cells, it would require the isolation of large numbers of viable crypts from the villi. In the past, we have isolated mouse crypts for patch-clamp studies (11, 29, 31) . In our hands, the crypt yield was adequate for the patch-clamp experiments; however, the quantity of isolated crypts would not be sufficient to determine cAMP levels. Therefore, at this time, we are unable to determine whether genistein alters cAMP levels within the crypt cell.
Genistein reduction of I sc in the presence of milrinone? Since we proposed that genistein and milrinone shared a common pathway in activating Cl Ϫ secretion, we were perplexed when genistein reduced the I sc in the presence of C696 milrinone, suggesting that genistein might be inhibiting Cl Ϫ secretion (Fig. 6, C and F) . Here, we discuss two possible interpretations of the effect of genistein on I sc in the presence of milrinone.
First, it has been reported that genistein can have both stimulatory and inhibitory effects on CFTR depending on the concentrations of genistein used (43, 66, 68) . Our milrinonegenistein results could be interpreted to suggest that genistein binds directly to nucleotide-binding domain 1 of CFTR in the presence of milrinone, thus, reducing the opening rate of CFTR, as described by Hwang and colleagues (66) . They (66) first demonstrated that genistein enhanced the channel current through CFTR in a concentration-dependent manner up to 35 M, while channel current fell with higher concentrations. Such an action by genistein could result in the reduced I sc observed in the presence of milrinone (Fig. 6, C and F) , although, in our study, this may not be the case, for the following reasons. First, we have previously reported that genistein increased I sc in a concentration-dependent (1-125 M) manner with no indication of a reduction in the I sc for the mouse (4). Additionally, we have used genistein at concentrations as high as 200 M with no indication of an inhibitory effect on I sc (Chao PC and Hamilton KL, unpublished observations), suggesting that, under our experimental conditions, genistein may not be directly inhibiting the action of CFTR, and thus, does not explain the reduced I sc in the presence of milrinone.
Alternatively, a simple interpretation for the reduced I sc by genistein in the presence of milrinone would be that genistein inhibited basolateral K ϩ channels. For instance, if K ϩ channels were inhibited by genistein, then the cellular potential would become more positive and this effect would reduce the driving force for Cl Ϫ exit via CFTR, resulting in a decrease in Cl Ϫ secretion. However, we have previously demonstrated that KCa3.1 was not involved in the genistein-stimulated Cl Ϫ secretory response of the mouse jejunum (4). Unfortunately, we were unable to locate any reports of the action of genistein on the cAMP-dependent K ϩ channel (K v 7.1) in epithelia. Nonetheless, genistein did not alter swelling-induced currents via K v 7.1 channels, which were expressed in COS7 cells (41) .
At present, our milrinone-genistein results are intriguing and require further study to elucidate the functional interactions of milrinone and genistein on the Cl Ϫ secretory response of the mouse jejunum.
In summary, we describe, for the first time, that genistein's stimulatory action on Cl Ϫ secretion in the mouse jejunum is PDE3 and PKA dependent. Our study provides additional basic functional information of the action of genistein in modulating the Cl Ϫ secretory response in a native epithelium. We need to understand the basic action of genistein on ion transport in epithelia to further the potential pharmacotherapeutic development and use of genistein in the treatment of diseases of epithelia.
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